Company registration number 12140625 (England and Wales)
MORLAND HOUSE HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
MORLAND HOUSE HEALTHCARE LIMITED
COMPANY INFORMATION
Directors
Dr DM Copping
Mr JS Gill
Dr AR Harnden
Secretary
Mrs K E Harnden
Company number
12140625
Registered office
Elthorne Gate
64 High Street
Pinner
HA5 5QA
Accountants
Aequitas Accountants Ltd
Elthorne Gate
64 High Street
Pinner
Middlesex
HA5 5QA
MORLAND HOUSE HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
MORLAND HOUSE HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
446,419
476,180
Tangible assets
4
71,068
88,134
517,487
564,314
Current assets
Stocks
97,697
85,483
Debtors
5
419,431
263,719
Cash at bank and in hand
371,978
255,858
889,106
605,060
Creditors: amounts falling due within one year
6
(484,073)
(445,177)
Net current assets
405,033
159,883
Total assets less current liabilities
922,520
724,197
Provisions for liabilities
(17,767)
(22,034)
Net assets
904,753
702,163
Capital and reserves
Called up share capital
300
300
Profit and loss reserves
904,453
701,863
Total equity
904,753
702,163
MORLAND HOUSE HEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 31 October 2025 and are signed on its behalf by:
Mr JS Gill
Director
Company registration number 12140625 (England and Wales)
MORLAND HOUSE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Morland House Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Elthorne Gate, 64 High Street, Pinner, HA5 5QA.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents revenue generated from the pharmacy and is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discount, settlement discounts and volume rebates.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is t wenty years.

For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% on reducing balance
Fixtures and fittings
25% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

MORLAND HOUSE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
13
13
MORLAND HOUSE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
595,225
Amortisation and impairment
At 1 April 2024
119,045
Amortisation charged for the year
29,761
At 31 March 2025
148,806
Carrying amount
At 31 March 2025
446,419
At 31 March 2024
476,180
4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Total
£
£
£
Cost
At 1 April 2024
41,935
116,364
158,299
Additions
-
0
11,630
11,630
Disposals
(8,900)
-
0
(8,900)
At 31 March 2025
33,035
127,994
161,029
Depreciation and impairment
At 1 April 2024
12,715
57,450
70,165
Depreciation charged in the year
6,054
17,636
23,690
Eliminated in respect of disposals
(3,894)
-
0
(3,894)
At 31 March 2025
14,875
75,086
89,961
Carrying amount
At 31 March 2025
18,160
52,908
71,068
At 31 March 2024
29,220
58,914
88,134
MORLAND HOUSE HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
378,389
195,962
Other debtors
25,509
51,314
Prepayments and accrued income
15,533
16,443
419,431
263,719
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
-
0
1
Trade creditors
301,690
300,622
Taxation and social security
156,922
136,453
Other creditors
25,461
8,101
484,073
445,177
7
Loans and overdrafts
2025
2024
£
£
Bank overdrafts
-
0
1
Payable within one year
-
0
1
8
Financial commitments, guarantees and contingent liabilities

As at the balance sheet date the total financial commitments are at £8,811. Th e s e commitments are for operating lease commitment for rent of the premises.

2025-03-31 2024-04-01 false false false 31 October 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Dr DM Copping Mr JS Gill Dr AR Harnden Mrs K E Harnden 12140625 2024-04-01 2025-03-31 12140625 bus:Director1 2024-04-01 2025-03-31 12140625 bus:Director2 2024-04-01 2025-03-31 12140625 bus:Director3 2024-04-01 2025-03-31 12140625 bus:CompanySecretary1 2024-04-01 2025-03-31 12140625 bus:RegisteredOffice 2024-04-01 2025-03-31 12140625 2025-03-31 12140625 2024-03-31 12140625 core:NetGoodwill 2025-03-31 12140625 core:NetGoodwill 2024-03-31 12140625 core:PlantMachinery 2025-03-31 12140625 core:FurnitureFittings 2025-03-31 12140625 core:PlantMachinery 2024-03-31 12140625 core:FurnitureFittings 2024-03-31 12140625 core:ShareCapital 2025-03-31 12140625 core:ShareCapital 2024-03-31 12140625 core:RetainedEarningsAccumulatedLosses 2025-03-31 12140625 core:RetainedEarningsAccumulatedLosses 2024-03-31 12140625 core:Goodwill 2024-04-01 2025-03-31 12140625 core:PlantMachinery 2024-04-01 2025-03-31 12140625 core:FurnitureFittings 2024-04-01 2025-03-31 12140625 2023-04-01 2024-03-31 12140625 core:NetGoodwill 2024-03-31 12140625 core:NetGoodwill 2024-04-01 2025-03-31 12140625 core:PlantMachinery 2024-03-31 12140625 core:FurnitureFittings 2024-03-31 12140625 2024-03-31 12140625 core:CurrentFinancialInstruments 2025-03-31 12140625 core:CurrentFinancialInstruments 2024-03-31 12140625 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12140625 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12140625 bus:FRS102 2024-04-01 2025-03-31 12140625 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12140625 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP